In April 2025, the US Food and Drug Administration (FDA) published a roadmap for leveraging new approach methodologies (NAMs), including in silico approaches such as artificial intelligence (AI), to ...

Innovation requires information, context, collaboration, experimentation, and even failure. Using simulation to make ...

Amphix Bio, a company spun out from Stupp’s Northwestern laboratory, is helping navigate the FDA approval process and has received early feedback from the agency on the drug development program for ...

Objectives Cardiac amyloidosis (CA) is a rare and underdiagnosed disease associated with a high mortality rate. Although, in ...

AI-driven robotics platform reduces drug formulation development time from years to months SACRAMENTO, Calif., May 19, 2025 /PRNewswire/ -- Persist AI, a pioneer in AI-driven robotics for ...

About Persist AI Persist AI is revolutionizing pharmaceutical development through AI-driven robotics for formulation development and CMC.

Serina Therapeutics to Present at the 4th LNP Formulation & Process Development Summit Provided by GlobeNewswire Apr 15, 2025, 3:30:00 AM ...

There is a need for design strategies that can support rapid and widespread deployment of new energy systems and process technologies. In a previous work, we introduced process family design as an ...

This work is framed in the context of Challenge-Based Learning and describes how mechatronic engineering students tackle a challenge using product design tools and ChatGPT. The challenge was part of ...

As consumer preference for ice cream evolves, formulations are evolving to meet demand. How can brands develop products to improve applications and the taste experience?

The process of drug discovery and development is both lengthy and intricate, demanding a substantial investment of time and financial resources. Bioinformatics techniques and tools can not only ...